Related Experiment Videos
p53 mutations have no additional prognostic value over stage in bladder cancer
J A Vet1, P P Bringuier, P J Poddighe
1Department of Urology, University Hospital, Nijmegen, The Netherlands.
British Journal of Cancer
|September 1, 1994
Summary
p53 mutations are linked to aggressive bladder cancer and genetic instability. While p53 mutations correlate with poor survival overall, their prognostic value in muscle-invasive tumors is limited, suggesting a role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The tumor-suppressor gene p53 is increasingly implicated in bladder cancer development.
- Understanding p53's role is crucial for diagnosing and treating bladder cancer.
Purpose of the Study:
- To investigate p53 gene mutations in bladder cancer.
- To correlate p53 mutations with tumor characteristics, genetic instability, and patient survival.
Main Methods:
- Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis was used to detect p53 mutations.
- 47 bladder tumors from 45 patients were analyzed.
- Frequency of Allelic Loss (FAL) and patient survival data were assessed.
Main Results:
- p53 mutations were identified in 8 out of 24 invasive, grade 3 bladder tumors, but not in superficial tumors.
- Tumors with p53 mutations exhibited a significantly higher Frequency of Allelic Loss (55.8% vs 21.1%), indicating increased genetic instability.
- A strong correlation was found between mutated p53 and poor survival in the overall study group (P < 0.001).
Conclusions:
- p53 mutations are associated with aggressive bladder cancer characteristics and genetic instability.
- While p53 mutations correlate with overall poor survival, they lack additional prognostic value in muscle-invasive bladder cancer.
- Further research is warranted to elucidate p53's role in the progression from superficial to invasive bladder cancer.